Zuoxiu Xiao

1.3k total citations · 1 hit paper
21 papers, 1.0k citations indexed

About

Zuoxiu Xiao is a scholar working on Biomedical Engineering, Materials Chemistry and Molecular Biology. According to data from OpenAlex, Zuoxiu Xiao has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Biomedical Engineering, 8 papers in Materials Chemistry and 6 papers in Molecular Biology. Recurrent topics in Zuoxiu Xiao's work include Nanoplatforms for cancer theranostics (12 papers), Advanced Nanomaterials in Catalysis (6 papers) and Advanced biosensing and bioanalysis techniques (4 papers). Zuoxiu Xiao is often cited by papers focused on Nanoplatforms for cancer theranostics (12 papers), Advanced Nanomaterials in Catalysis (6 papers) and Advanced biosensing and bioanalysis techniques (4 papers). Zuoxiu Xiao collaborates with scholars based in China and United States. Zuoxiu Xiao's co-authors include Kelong Ai, Qiong Huang, Yuqi Yang, Qiaohui Chen, Tianjiao Zhao, Yayun Nan, Yitian Jiang, Yunrong Yang, Yige Qiu and Yuting Xiang and has published in prestigious journals such as Advanced Materials, Advanced Functional Materials and Chemical Engineering Journal.

In The Last Decade

Zuoxiu Xiao

20 papers receiving 1.0k citations

Hit Papers

Emerging Sonodynamic Therapy‐Based Nanomedicines for Canc... 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zuoxiu Xiao China 17 524 308 280 162 104 21 1.0k
Yayun Nan China 18 547 1.0× 447 1.5× 419 1.5× 195 1.2× 119 1.1× 31 1.3k
Tianjiao Zhao China 19 523 1.0× 373 1.2× 453 1.6× 182 1.1× 159 1.5× 32 1.4k
Christopher J. Kutyreff United States 16 650 1.2× 549 1.8× 437 1.6× 222 1.4× 85 0.8× 26 1.4k
Chaoqiang Qiao China 13 370 0.7× 158 0.5× 498 1.8× 103 0.6× 134 1.3× 24 940
Xu-Qi Kang China 18 336 0.6× 124 0.4× 304 1.1× 271 1.7× 80 0.8× 22 1.0k
Zheng Pan China 10 229 0.4× 150 0.5× 227 0.8× 106 0.7× 68 0.7× 28 764
Cailian Wang China 19 442 0.8× 280 0.9× 390 1.4× 261 1.6× 85 0.8× 53 1.4k
Yunrong Yang China 8 302 0.6× 196 0.6× 180 0.6× 97 0.6× 79 0.8× 10 608
Meng Jia China 19 427 0.8× 130 0.4× 482 1.7× 220 1.4× 223 2.1× 36 1.4k
Nidhi Raval India 16 608 1.2× 256 0.8× 511 1.8× 583 3.6× 97 0.9× 25 1.4k

Countries citing papers authored by Zuoxiu Xiao

Since Specialization
Citations

This map shows the geographic impact of Zuoxiu Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuoxiu Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuoxiu Xiao more than expected).

Fields of papers citing papers by Zuoxiu Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zuoxiu Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuoxiu Xiao. The network helps show where Zuoxiu Xiao may publish in the future.

Co-authorship network of co-authors of Zuoxiu Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Zuoxiu Xiao. A scholar is included among the top collaborators of Zuoxiu Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zuoxiu Xiao. Zuoxiu Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Qiaohui, Zuoxiu Xiao, Jianlin Chen, et al.. (2025). Molybdenum-bridged endo-exogenous antioxidant synergy reverses acute kidney injury via mitochondrial homeostasis reconstruction. Bioactive Materials. 54. 777–796.
2.
Long, Xingyu, Min Liu, Yayun Nan, et al.. (2024). Revitalizing Ancient Mitochondria with Nano‐Strategies: Mitochondria‐Remedying Nanodrugs Concentrate on Disease Control. Advanced Materials. 36(18). e2308239–e2308239. 55 indexed citations
3.
4.
Song, Xiangping, Qiong Huang, Yuqi Yang, et al.. (2023). Efficient Therapy of Inflammatory Bowel Disease (IBD) with Highly Specific and Durable Targeted Ta2C Modified with Chondroitin Sulfate (TACS). Advanced Materials. 35(36). e2301585–e2301585. 69 indexed citations
5.
Yang, Yuqi, Yayun Nan, Qiaohui Chen, et al.. (2023). Antioxidative 0-dimensional nanodrugs overcome obstacles in AKI antioxidant therapy. Journal of Materials Chemistry B. 11(34). 8081–8095. 7 indexed citations
6.
Huang, Qiong, Yuqi Yang, Yan Zhu, et al.. (2023). Oral Metal‐Free Melanin Nanozymes for Natural and Durable Targeted Treatment of Inflammatory Bowel Disease (IBD). Small. 19(19). e2207350–e2207350. 109 indexed citations
7.
Xiang, Yuting, Qiaohui Chen, Yayun Nan, et al.. (2023). Nitric Oxide‐Based Nanomedicines for Conquering TME Fortress: Say “NO” to Insufficient Tumor Treatment. Advanced Functional Materials. 34(13). 25 indexed citations
8.
Yang, Yunrong, Jia Huang, Min Liu, et al.. (2022). Emerging Sonodynamic Therapy‐Based Nanomedicines for Cancer Immunotherapy. Advanced Science. 10(2). e2204365–e2204365. 180 indexed citations breakdown →
9.
Xiang, Yuting, Nian‐Sheng Li, Min Liu, et al.. (2022). Nanodrugs Detonate Lysosome Bombs. Frontiers in Pharmacology. 13. 909504–909504. 9 indexed citations
10.
Long, Xingyu, Xiaojie Zhang, Qiaohui Chen, et al.. (2022). Nucleus-Targeting Phototherapy Nanodrugs for High-Effective Anti-Cancer Treatment. Frontiers in Pharmacology. 13. 905375–905375. 18 indexed citations
11.
Zhao, Haixin, Jia Huang, Lulu Huang, et al.. (2022). Surface control approach for growth of cerium oxide on flower-like molybdenum disulfide nanosheets enables superior removal of uremic toxins. Journal of Colloid and Interface Science. 630(Pt B). 855–865. 16 indexed citations
12.
Chen, Qiaohui, Yayun Nan, Yuqi Yang, et al.. (2022). Nanodrugs alleviate acute kidney injury: Manipulate RONS at kidney. Bioactive Materials. 22. 141–167. 89 indexed citations
13.
Yang, Yuqi, Qiong Huang, Zuoxiu Xiao, et al.. (2022). Nanomaterial-based biosensor developing as a route toward in vitro diagnosis of early ovarian cancer. Materials Today Bio. 13. 100218–100218. 47 indexed citations
14.
Xiao, Zuoxiu, Qiong Huang, Yuqi Yang, et al.. (2022). Emerging early diagnostic methods for acute kidney injury. Theranostics. 12(6). 2963–2986. 56 indexed citations
15.
Liu, Min, Yuting Xiang, Yuqi Yang, et al.. (2022). State-of-the-art advancements in Liver-on-a-chip (LOC): Integrated biosensors for LOC. Biosensors and Bioelectronics. 218. 114758–114758. 17 indexed citations
16.
Zhao, Haixin, Jia Huang, Miao Lü, et al.. (2022). Toward Urease-free wearable artificial kidney: Widened interlayer spacing MoS2 nanosheets with highly effective adsorption for uremic toxins. Chemical Engineering Journal. 438. 135583–135583. 21 indexed citations
17.
Yang, Yuqi, Tianjiao Zhao, Qiaohui Chen, et al.. (2022). Nanomedicine Strategies for Heating “Cold” Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC. Advanced Science. 9(28). e2202797–e2202797. 41 indexed citations
18.
Chen, Li, Qiong Huang, Tianjiao Zhao, et al.. (2021). Nanotherapies for sepsis by regulating inflammatory signals and reactive oxygen and nitrogen species: New insight for treating COVID-19. Redox Biology. 45. 102046–102046. 71 indexed citations
19.
Li-hua, Sui, Jianling Wang, Zuoxiu Xiao, et al.. (2020). ROS-Scavenging Nanomaterials to Treat Periodontitis. Frontiers in Chemistry. 8. 595530–595530. 74 indexed citations
20.
Li, Nian‐Sheng, Li Chen, Zuoxiu Xiao, Yuqi Yang, & Kelong Ai. (2020). Progress in Detection of Biomarker of Ovarian Cancer: Lysophosphatidic Acid. Chinese Journal of Analytical Chemistry. 48(12). 1597–1606. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026